A hybrid PDE-agent model shows that tumor blood vessels shield resistant cells and that early, frequent mutations plus high proliferation reinforce drug resistance, explaining conflicting T790M findings.
Optimization of dosing for egfr-mutant non–small cell lung cancer with evolutionary cancer modeling
1 Pith paper cite this work. Polarity classification is still indexing.
1
Pith paper citing it
citation-role summary
background 1
citation-polarity summary
fields
math.NA 1years
2025 1verdicts
CONDITIONAL 1roles
background 1polarities
unclear 1representative citing papers
citing papers explorer
-
A hybrid PDE-ABM model for angiogenesis and tumour microenvironment with application to resistance in cancer treatment
A hybrid PDE-agent model shows that tumor blood vessels shield resistant cells and that early, frequent mutations plus high proliferation reinforce drug resistance, explaining conflicting T790M findings.